U.S. Food and Drug Administration Corporate Counsel Salaries in Baltimore, MD
The average U.S. Food and Drug Administration Corporate Counsel in Baltimore, MD earns an estimated $204,101 annually, which includes an estimated base salary of $177,387 with a $26,714 bonus. U.S. Food and Drug Administration's Corporate Counsel compensation is $25,757 more than the US average for a Corporate Counsel. Corporate Counsel salaries at U.S. Food and Drug Administration in Baltimore, MD can range from $153,000 - $280,000.
In Baltimore, MD, The Legal Department at U.S. Food and Drug Administration earns $6,494 more on average than the Marketing Department.
Last updated 3 years ago.
- $177,387
- avg. base
- $26,714
- avg. bonus
Corporate Counsel Salaries at U.S. Food and Drug Administration
In Baltimore, MD, Corporate Counsels earn $3,040 more than Corporate Counsels, and $1,710 less than General Counsels.
Compensation at U.S. Food and Drug Administration by Department
In Baltimore, MD, The Legal Department averages $6,494 more than the Marketing Department, and $150 less than the Customer Support Department
Corporate Counsel Compensation by Gender (All Companies)
The average female Corporate Counsel at companies similar size to U.S. Food and Drug Administration reported making $190,419, while the average male Corporate Counsel at similar sized companies reported making $218,835.
Corporate Counsel Compensation by Ethnicity (All Companies)
The average Caucasian Corporate Counsel at companies similar size to U.S. Food and Drug Administration reported making $215,700, while the average Asian or Pacific Islander Corporate Counsel at similar sized companies reported making $176,738.
How Corporate Counsels at U.S. Food and Drug Administration Rate Their Compensation
The majority of Corporate Counsels at U.S. Food and Drug Administration believe they're compensated fairly. 100% of Corporate Counsels at U.S. Food and Drug Administration say they receive annual bonuses, and the vast majority (71%) are satisfied with their benefits. See more compensation ratings at U.S. Food and Drug Administration
